SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C. 20549

                                    FORM 15

Certification and Notice of Termination of Registration under Section 12(g) of 
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under 
         Sections 13 and 15(d) of the Securities Exchange Act of 1934

                        Commission File Number:      1-14142
                                                --------------------------------

                         Renal Treatment Centers, Inc.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

21250 Hawthorne Boulevard, Suite 800, Torrance, California 90503-(310) 792-2600
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of 
                   registrant's principal executive offices)

                        Common Stock, ($.01 par value)
             5-5/8% Senior Convertible Subordinated Notes due 2006
- --------------------------------------------------------------------------------
           (Title of each class of securities covered by this Form)

                                     None
- --------------------------------------------------------------------------------
(Title of all other classes of securities for which a duty to file reports under
                        Section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:

               Rule 12g-4(a)(1)(i)  [X]            Rule 12h-3(b)(1)(ii) [ ]
               Rule 12g-4(a)(1)(ii) [ ]            Rule 12h-3(b)(2)(i)  [ ]
               Rule 12g-4(a)(2)(i)  [ ]            Rule 12h-3(b)(2)(ii) [ ]
               Rule 12g-4(a)(2)(ii) [ ]            Rule 15d-6           [X]
               Rule 12h-3(b)(1)(i)  [ ]

     Approximate number of holders of record as of the certification or notice
date:     One
      ------------

Pursuant to the requirements of the Securities Exchange Act of 1934, Total Renal
Care, Inc. has caused this certification/notice to be signed on its behalf by
the undersigned duly authorized person.


DATE:  March 31, 1998                   By:  /s/ John E. King
     ----------------------                ----------------------
                                           John E. King, Vice President Finance
                                           and Chief Financial Officer

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the 
General Rules and regulations under the Securities Exchange Act of 1934. the 
registrant shall file with the Commission three copies of Form 15, one of which 
shall be manually signed. It may be signed by an officer of the registrant, by 
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.